Stanley C Erck
CIK 1342826 · President and CEO · last filed 2026-06-22
Stanley C Erck is a President and CEO who has filed 70 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for MXCT, was dated Jun 22, 2026. Across all open-market trades the lifetime net is −$51.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.34M
4
70
-$50.97M
Filer Profile
GAITHERSBURG, MD 20878
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MXCT | Director | 428,749 | $1.25 | $533.8K | -$410.6K | 10 | 2026-06-22 |
| NVAX | President and CEO | 36,492 | $9.87 | $360.2K | -$49.70M | 42 | 2022-12-16 |
| BCRX | Director | 48,333 | $9.14 | $442.0K | $48.9K | 12 | 2018-11-30 |
| INTERCELL USA, INC. (IOMI) Delisted | President & CEO | 33,201 | — | — | -$906.2K | 4 | 2008-07-31 |
Recent Filings
70 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-22 | MXCT | Grant (A) | +30,421 | $0 | EDGAR |
| 2025-08-13 | MXCT | Buy (P) | +100,000 | $137.2K | EDGAR |
| 2025-06-23 | MXCT | Grant (A) | +29,210 | $0 | EDGAR |
| 2024-11-05 | MXCT | Mixed | — | -$175.5K | EDGAR |
| 2024-10-02 | MXCT | Mixed | — | -$176.8K | EDGAR |
| 2024-09-05 | MXCT | Mixed | — | -$189.7K | EDGAR |
| 2024-09-03 | MXCT | Notice (144) | −143,067 | -$618.0K | EDGAR |
| 2024-06-13 | MXCT | Grant (A) | +21,367 | $0 | EDGAR |
| 2023-06-23 | MXCT | Grant (A) | — | $0 | EDGAR |
| 2022-12-16 | NVAX | Mixed | +4,646 | -$40.0K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.